DEMİRCİ, N. Et Al. 2016. Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study. 2016 ASCO Annual Meeting .

DEMİRCİ, N., AKSOY, S., ÖZDEMİR, N., Babacan, T., ERDEM, G. U., BOZKAYA, Y., ... ZENGİN, N.(2016). Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study . 2016 ASCO Annual Meeting

DEMİRCİ, NECİP Et Al. "Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study," 2016 ASCO Annual Meeting, 2016

DEMİRCİ, NECİP Et Al. "Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study." 2016 ASCO Annual Meeting , 2016

DEMİRCİ, N. Et Al. (2016) . "Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study." 2016 ASCO Annual Meeting .

@conferencepaper{conferencepaper, author={NECİP DEMİRCİ Et Al. }, title={Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study}, congress name={2016 ASCO Annual Meeting}, city={}, country={}, year={2016}}